Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityTumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatbiotin conjugate
Size0.1 mg, 0.2 mg, 1 mg
Concentration200ug/ml
ApplicationsImmunohistochemistry (IHC), ELISA (EIA), Western Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThe antibody is a rabbit polyclonal antibody raised against TNFRSF9 conjugated to biotin. It has been selected for its ability to recognize TNFRSF9 in immunohistochemical staining andwestern blotting.
Immunogenn/a
Other Names[tumor necrosis factor receptor superfamily member 9; Tumor necrosis factor receptor superfamily member 9; tumor necrosis factor receptor superfamily member 9; CD137 antigen; T cell antigen ILA; T-cell antigen ILA; 4-1BB ligand receptor; homolog of mouse 4-1BB; receptor protein 4-1BB; T-cell antigen 4-1BB homolog; induced by lymphocyte activation (ILA); interleukin-activated receptor, homolog of mouse Ly63; tumor necrosis factor receptor superfamily, member 9; 4-1BB ligand receptor; CDw137; T-cell antigen 4-1BB homolog; T-cell antigen ILA]
Gene, Accession #[TNFRSF9], Gene ID: 3604, NCBI: NP_001552.2, UniProt: Q07011
Catalog #MBS2002004
Price$235, $350, $835
Order / More InfoTumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.